No record found
No record found
No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
| Qawi Naseer | CEO |
| Farhan Muhammad Haroon | Chairperson |
| Mashal Mohammad | Company Secretary |
11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600
CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
M/s KPMG Taseer Hadi & Co. Chartered Accountants
December
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Oct 30, 2025 | Transmission of Quarterly Report for the Period Ended 30 September 2025 | View PDF |
| Oct 27, 2025 | Financial Results for the Quarter Ended 30 September 2025 | View PDF |
| Aug 29, 2025 | Transmission of Quarterly Report for the Period Ended 30 June 2025 | View PDF |
| Aug 26, 2025 | Financial Results for the Quarter Ended 30 June 2025 | View PDF |
| Apr 30, 2025 | Transmission of Quarterly Report for the Period Ended 31 March 2025 | View PDF |
| Date | Title | Document |
|---|---|---|
| Oct 20, 2025 | Notice of Board of Directors Meeting - (Q3-2025) | View PDF |
| Aug 18, 2025 | Notice of Board of Directors Meeting - (Q2-2025) | View PDF |
| Apr 18, 2025 | Notice of Board of Directors Meeting - (Q1-2025) | View PDF |
| Mar 20, 2025 | CTC of Resolutions Passed in the Annual General Meeting 2024 | View PDF |
| Feb 27, 2025 | Notice of Annual General Meeting | View PDF |
| Date | Title | Document |
|---|---|---|
| Dec 3, 2025 | Disclosure of Material Information | View PDF |
| Nov 19, 2025 | Presentation for Corporate Briefing Session 2025 | View PDF |
| Nov 14, 2025 | Notice of Corporate Briefing Session 2025 | View PDF |
| Nov 14, 2025 | Credit of Second Interim Cash Dividend | View PDF |
| Nov 13, 2025 | Prior Publication of Notice of Credit of Second Interim Cash Dividend | View PDF |
Financials
All numbers in thousands (000's) except EPS
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 37,205,893 | 31,609,776 | 27,507,212 | 24,163,150 |
| Profit after Taxation | 4,578,247 | 995,586 | 325,411 | 2,134,334 |
| EPS | 39.11 | 8.51 | 2.78 | 18.23 |
| Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | |
|---|---|---|---|---|
| Sales | 10,562,883 | 11,598,087 | 10,029,843 | 9,754,500 |
| Profit after Taxation | 1,615,006 | 1,623,159 | 1,347,596 | 1,329,784 |
| EPS | 13.80 | 13.87 | 11.51 | 11.36 |

Ratios
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 34.45 | 20.40 | 17.40 | 27.38 |
| Net Profit Margin (%) | 12.31 | 3.15 | 1.18 | 8.83 |
| EPS Growth (%) | 359.58 | 206.12 | (84.75) | 69.11 |
| PEG | 0.06 | 0.10 | (0.70) | 0.19 |
Payouts
| Date | Financial Results | Details | Book Closure |
|---|---|---|---|
| October 27, 2025 3:59 PM | 30/09/2025(IIIQ) | 50%(ii) (D) | 06/11/2025 - 07/11/2025 |
| August 26, 2025 3:52 PM | 30/06/2025(HYR) | 100%(i) (D) | 04/09/2025 - 05/09/2025 |
| February 6, 2025 4:23 PM | 31/12/2024(YR) | 150%(F) (D) | 13/03/2025 - 20/03/2025 |
| October 25, 2024 4:20 PM | 30/09/2024(IIIQ) | 50% (i) (D) | 07/11/2024 - 08/11/2024 |









Feedback
Terms of Use
https://www.psx.com.pk